Hot Features
Premium
Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Período:
Tipo de Línea:
| Volume | 573,989 |
|
|||||
| Noticias | - | ||||||
| Máximo del Dia | 48.23 | Mínimo Máximo |
|||||
| Minimo del Dia | 46.51 | ||||||
| Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
|---|---|---|---|
| Janux Therapeutics Inc | JANX | NASDAQ | Acción Común |
| Variación del Día (ptos.) | Variación del Día (%) | Último Precio | Hora
|
|
|---|---|---|---|---|
| 0.29 | 0.62% | 47.39 | 19:00:00 |
| Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
|---|---|---|---|---|
| 47.08 | 46.51 | 48.23 | 47.39 | 47.10 |
| Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
|---|---|---|---|---|---|
| 10,386 | 573,989 | US$ 47.38 | US$ 27,195,057 | - | 5.65 - 58.6936 |
| Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
|---|---|---|---|---|
| 18:30:14 | 1 | US$ 47.50 | USD |
Flujo de Opciones Janux Therapeutics (JANX)
Información Financiera Janux Therapeutics Inc JANX
| Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
|---|---|---|---|---|---|---|
| 2.45B | 51.66M | - | 8.08M | -58.29M | -1.13 | - |
| Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
|---|---|---|---|---|---|
| - | - | - | - |
Noticias sobre Janux Therapeutics Inc JANX
| Fecha | Hora | Fuente | Noticias Artículo |
|---|---|---|---|
| 08/3/2024 | 15:47 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
| 08/3/2024 | 15:23 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
| 08/3/2024 | 15:11 | Edgar (US Regulatory) | Form 8-K - Current report |
| 08/3/2024 | 15:01 | Business Wire | Janux Therapeutics Reports Fourth Quarter and Full Year 2023.. |
| 29/2/2024 | 16:30 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 29/2/2024 | 16:11 | Edgar (US Regulatory) | Form 8-K - Current report |
| 29/2/2024 | 00:22 | Business Wire | Janux Therapeutics Announces Pricing of $296.5 Million.. |
| 28/2/2024 | 20:55 | Edgar (US Regulatory) | Form FWP - Filing under Securities Act Rules 163/433 of free.. |
| 28/2/2024 | 16:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 27/2/2024 | 20:50 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 27/2/2024 | 16:23 | Edgar (US Regulatory) | Form 8-K - Current report |
| 27/2/2024 | 16:00 | Business Wire | Janux Therapeutics Announces Proposed Public Offering of.. |
Histórico de Datos JANX
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 48.60 | 50.42 | 44.71 | 48.64 | 726,097 | -1.21 | -2.49% |
| 1 Month | 37.62 | 56.27 | 34.63 | 46.81 | 867,245 | 9.77 | 25.97% |
| 3 Months | 8.29 | 58.6936 | 7.79 | 44.20 | 1,004,288 | 39.10 | 471.65% |
| 6 Months | 6.16 | 58.6936 | 5.65 | 40.05 | 527,957 | 41.23 | 669.32% |
| 1 Year | 14.66 | 58.6936 | 5.65 | 34.94 | 319,631 | 32.73 | 223.26% |
| 3 Years | 34.00 | 58.6936 | 5.65 | 28.92 | 186,576 | 13.39 | 39.38% |
| 5 Years | 34.00 | 58.6936 | 5.65 | 28.92 | 186,576 | 13.39 | 39.38% |
